STADA Arzneimittel AG reported turnover at its Branded Products business up 22% to €632m ($747m) in the first half of 2020 as a series of consumer health acquisitions across Europe and Asia drove up sales. The German group hinted that further deals could follow, noting that it was continuing to look at a range of business development opportunities.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?